Header Logo

Connection

Francesca CONRADIE to Tuberculosis, Pulmonary

Back to Details
This is a "connection" page, showing publications Francesca CONRADIE has written about Tuberculosis, Pulmonary.
Francesca CONRADIE
Connection Strength
1,281
Tuberculosis, Pulmonary
  1. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. Reply. N Engl J Med. 2020 06 11; 382(24):2377.
    View in: PubMed
    Score: 0,546
  2. Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis. N Engl J Med. 2024 Dec 19; 391(24):2315-2326.
    View in: PubMed
    Score: 0,187
  3. Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial. Lancet Infect Dis. 2024 Sep; 24(9):1003-1014.
    View in: PubMed
    Score: 0,179
  4. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med. 2020 03 05; 382(10):893-902.
    View in: PubMed
    Score: 0,134
  5. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med. 2019 03 28; 380(13):1201-1213.
    View in: PubMed
    Score: 0,125
  6. Turning the tide against tuberculosis. Int J Infect Dis. 2017 Mar; 56:6-9.
    View in: PubMed
    Score: 0,108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.